Recurrence of intracranial tumors following adoptive T cell therapy can be prevented by direct and indirect killing aided by high levels of tumor antigen cross-presented on stromal cells.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples